Trial Profile
Takepron Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Gastritis
- Focus Adverse reactions
- Sponsors Takeda
- 10 Jun 2014 New trial record